Search Publications

Publications

Pubmed ID Author Year Title

24569407

Grigoryan O

2014

Effect of metformin on the level of anti-Mullerian hormone in therapy of polycystic ovary syndrome in obese women.

24569609

Vals MA

2014

Coffin-Siris Syndrome with obesity, macrocephaly, hepatomegaly and hyperinsulinism caused by a mutation in the ARID1B gene.

24576224

El Hachem H

2014

Live birth after frozen-thawed oocytes matured in vitro in a PCOS patient: a model for improving implantation rates in IVM cycles and objectively assessing the real potential of development of frozen oocytes matured in vitro.

24576225

Tsouma I

2014

Correlation of visfatin levels and lipoprotein lipid profiles in women with polycystic ovary syndrome undergoing ovarian stimulation.

24576416

Gonz?lez F

2014

Glucose and lipopolysaccharide regulate proatherogenic cytokine release from mononuclear cells in polycystic ovary syndrome.

24576485

Abuelghar WM

2014

Women with clomiphene citrate resistant polycystic ovarian disease: predictors of spontaneous ovulation after laparoscopic ovarian drilling.

24577156

A?maz G

2014

Evaluation of the Macula, Retinal Nerve Fiber Layer, and Choroid Thickness in Women With Polycystic Ovary Syndrome Using Spectral-Domain Optical Coherence Tomography.

24579361

Sun J

2013

[Effects of electroacupuncture of Guanyuan (CV 4)-Zhongji (CV 3) on ovarian P450 arom and P450c 17alpha expression and relevant sex hormone levels in rats with polycystic ovary syndrome].

24581575

Chin V

2014

Gonadal dysfunction in morbidly obese adolescent girls.

24581983

Wissing ML

2014

Impact of PCOS on early embryo cleavage kinetics.

24582095

Nandi A

2014

Polycystic ovary syndrome.

24583185

Van Vugt DA

2014

Glucose-induced inhibition of the appetitive brain response to visual food cues in polycystic ovary syndrome patients.

24584741

Aye MM

2014

Acute hypertriglyceridemia induces platelet hyperactivity that is not attenuated by insulin in polycystic ovary syndrome.

24585089

Gao H

2014

Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women.

24586979

Foix-L'H?lias L

2014

Growth development of French children born after in vitro maturation.

24589963

Buyukkaya R

2014

The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome.

24591551

Lerchbaum E

2014

Influence of a positive family history of both type 2 diabetes and PCOS on metabolic and endocrine parameters in a large cohort of PCOS women.

24591680

Duncan WC

2014

A guide to understanding polycystic ovary syndrome (PCOS).

24591981

Bhattacharya SM

2011

Effects of drospirenone pill in Indian women with polycystic ovary syndrome.

24592013

Ozcan A

2012

Total and lipid bound sialic acid levels in patients with polycystic ovary syndrome.

24592034

Ersan F

2012

Prediction of metabolic syndrome in women with polycystic ovary syndrome.

24592047

G?d?c? N

2012

C-reactive protein and lipoprotein-a as markers of coronary heart disease in polycystic ovary syndrome.

24592051

Dilbaz B

2012

Health related quality of life among different PCOS phenotypes of infertile women.

24592098

Karak?se M

2013

The metabolic effects of drugs used for the treatment of polycystic ovary syndrome.

24592109

Karak?se M

2013

Is there a link between polycystic ovary syndrome and non-thyroidal illness syndrome?

24592113

Yal??nkaya E

2013

In vitro maturation may prevent the cancellation of in vitro fertilization cycles in poor responder patients: A case report.

24592646

Neff KJ

2014

A holistic assessment of bariatric surgical outcomes in a Northern Irish cohort.

24592911

Porwal S

2014

Periodontal status and high-sensitivity C-reactive protein levels in polycystic ovary syndrome with and without medical treatment.

24592983

Bassiouny YA

2014

Association of the luteinizing hormone/choriogonadotropin receptor gene polymorphism with polycystic ovary syndrome.

24592984

Shahin AY

2014

Adding the phytoestrogen Cimicifugae Racemosae to clomiphene induction cycles with timed intercourse in polycystic ovary syndrome improves cycle outcomes and pregnancy rates - a randomized trial.

24592986

Snyder ML

2014

Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls.

24593700

Livingstone C

2014

Insulin-like growth factor-II: its role in metabolic and endocrine disease.

24593938

Tal R

2014

Characterization of women with elevated antim?llerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.

24594076

Kelekci S

2014

Ultra-short term clomiphene citrate in high responder women with polycystic ovary syndrome: a case series.

24594504

Petrosino JM

2014

Aldehyde dehydrogenase 1A1: friend or foe to female metabolism?

24595965

Helseth R

2014

Maternal and fetal insulin levels at birth in women with polycystic ovary syndrome: data from a randomized controlled study on metformin.

24597249

Itoh H

2013

The role of serum adiponectin levels in women with polycystic ovarian syndrome.

24597271

Murakami M

2013

Ovarian torsion associated with cessation of hormonal treatment for polycystic ovarian syndrome: a case report.

24597283

Yazici G

2014

Role of luteal phase support on gonadotropin ovulation induction cycles in patients with polycystic ovary syndrome.

24597291

K???? N

2014

Effect of underlying infertility factors on second trimester serum screening results.

24601829

Genazzani AD

2014

Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients.

24601936

Androulakis II

2014

Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.

24602301

Karacan E

2014

Body satisfaction and eating attitudes among girls and young women with and without polycystic ovary syndrome.

24602474

Melo AS

2014

Small for gestational age babies are not related to changes in markers of adipose tissue dysfunction during reproductive age.

24606085

Sjaarda LA

2014

Increased androgen, anti-M?llerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?

24606093

Pau CT

2014

Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.

24606098

Dokras A

2014

Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?

24606102

Irani M

2014

Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS.

24606639

Genazzani AD

2014

Myo-inositol modulates insulin and luteinizing hormone secretion in normal weight patients with polycystic ovary syndrome.

24607253

van Houten EL

2014

Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?

24610422

Yu M

2014

Polymorphisms of pentanucleotide repeats (tttta)n in the promoter of CYP11A1 and their relationships to polycystic ovary syndrome (PCOS) risk: a meta-analysis.

24611738

Shen WJ

2014

Relationships between TCF7L2 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis.

24612019

Ta?olar H

2014

Assessment of atrial electromechanical delay in patients with polycystic ovary syndrome in both lean and obese subjects.

24612081

Ebrahimi-Mamaghani M

2014

Effects of raw red onion consumption on metabolic features in overweight or obese women with polycystic ovary syndrome: a randomized controlled clinical trial.

24612181

Tan BK

2014

Circulatory changes of the novel adipokine adipolin/CTRP12 in response to metformin treatment and an oral glucose challenge in humans.

24613538

Kim JJ

2014

Complete phenotypic and metabolic profiles of a large consecutive cohort of untreated Korean women with polycystic ovary syndrome.

24615567

Saleh HA

2014

Polycystic ovarian syndrome and congenital uterine anomalies: the hidden common player.

24615662

Skorupskaite K

2014

The kisspeptin-GnRH pathway in human reproductive health and disease.

24617798

Amaral FG

2014

Environmental control of biological rhythms: effects on development, fertility and metabolism.

24618762

Walzem RL

2014

Obesity-induced dysfunctions in female reproduction: lessons from birds and mammals.

24626805

Han X

2014

Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.

24626943

Maciel GA

2014

Association of glucocorticoid receptor polymorphisms with clinical and metabolic profiles in polycystic ovary syndrome.

24627671

G?ren K

2012

Plasma apelin levels in patients with polycystic ovary syndrome.

24628003

K???k M

2014

Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.

24628390

Bahmani F

2014

The effects of folate supplementation on inflammatory factors and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial.

24628831

Karbek B

2014

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.

24628852

Maurya VK

2014

Expression and activity of Rac1 is negatively affected in the dehydroepiandrosterone induced polycystic ovary of mouse.

24628922

Hong JS

2015

Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients.

24630294

Ashrafi M

2014

Risk of gestational diabetes mellitus in patients undergoing assisted reproductive techniques.

24630573

Weintraub A

2014

The dynamics of serum anti-Mullerian-hormone levels during controlled ovarian hyperstimulation with GnRH-antagonist short protocol in polycystic ovary syndrome and low responders.

24631839

Cuzzola A

2014

A comprehensive study for the validation of a LC-MS/MS method for the determination of free and total forms of urinary cortisol and its metabolites.

24634287

K?se SA

2014

Selenium reduces oxidative stress and calcium entry through TRPV1 channels in the neutrophils of patients with polycystic ovary syndrome.

24636134

Barry JA

2014

Reporting the rates of depression in polycystic ovary syndrome (PCOS).

24636395

Raja-Khan N

2014

High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial.

24637052

Zhang XJ

2014

Characterizing plasma phospholipid fatty acid profiles of polycystic ovary syndrome patients with and without insulin resistance using GC-MS and chemometrics approach.

24639686

Khalili MA

2013

Contribution of human oocyte architecture to success of in vitro maturation technology.

24639696

Gozashti MH

2013

Relationship between serum cystatin C and polycystic ovary syndrome.

24639704

Bazarganipour F

2013

Body image satisfaction and self-esteem status among the patients with polycystic ovary syndrome.

24639712

Swellam M

2013

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI.

24639731

Salehpour S

2013

Antithyroid peroxidase antibodies in women with polycystic ovary syndrome.

24639732

Dayer D

2013

Comparison of leptin concentrations between infertile women with polycystic ovary syndrome and fertile women.

24639745

Ramezani Tehrani F

2013

Relationship between polymorphism of insulin receptor gene, and adiponectin gene with PCOS.

24639797

Amooee S

2013

Metformin versus chromium picolinate in clomiphene citrate-resistant patients with PCOs: A double-blind randomized clinical trial.

24639805

Nadjarzadeh A

2013

The effect of omega-3 supplementation on androgen profile and menstrual status in women with polycystic ovary syndrome: A randomized clinical trial.

24639812

Qu Z

2013

The clinical characteristics and etiological study of nonalcoholic fatty liver disease in Chinese women with PCOS.

24639816

Bazarganipour F

2013

Iranian version of modified polycystic ovary syndrome health-related quality of Life questionnaire: Discriminant and convergent validity.

24641817

Rall K

2014

Acne and PCOS are less frequent in women with Mayer-Rokitansky-K?ster-Hauser syndrome despite a high rate of hyperandrogenemia: a cross-sectional study.

24641921

Mott MM

2014

Practice Patterns in Screening for Metabolic Disease in Women with PCOS of Diverse Race-Ethnic Backgrounds.

24642195

Altinkaya S?

2014

Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.

24642641

Lin H

2014

Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs.

24643690

Xu L

2014

Association between ghrelin gene variations, body mass index, and waist-to-hip ratio in patients with polycystic ovary syndrome.

24643692

D?neas? A

2014

Spironolactone and dimethylsulfoxide effect on glucose metabolism and oxidative stress markers in polycystic ovarian syndrome rat model.

24643802

Keskin Kurt R

2014

The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study.

24646063

Xiao S

2014

Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients.

24646256

Tatone C

2014

Dicarbonyl stress and glyoxalases in ovarian function.

24648300

Caner S

2014

M30 does not predict the severity of hepatosteatosis, whereas adiponectin level declined with increase of ALT and the severity of hepatic steatosis.

24649096

Baldani DP

2014

Association of <i>PPARG</i> Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome.

24649106

Ferk P

2014

Association of -108 C>T <i>PON1</i> polymorphism with polycystic ovary syndrome.

24650676

Tsai YH

2014

Dietary intake, glucose metabolism, and sex hormones in women with polycystic ovary syndrome (PCOS) compared with women with non-PCOS-related infertility - CORRIGENDUM.

24654474

Caserta D

2014

A 29-year-old woman with complex atypical hyperplasia and polycystic ovary syndrome: a challenging issue.